Fluoxetine, fluvoxamine and extrapyramidal tract disorders.
Baldwin
D
D
Academic Department of Psychiatry, St Mary's Hospital Medical School, London, UK.
Fineberg
N
N
Montgomery
S
S
D000328:Adult; D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000503:physiopathology; D005260:Female; D005473:Fluoxetine / Q000009:adverse effects* / Q000627:therapeutic use; D016666:Fluvoxamine; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D009068:Movement / Q000187:drug effects; D010091:Oximes / Q000009:adverse effects* / Q000627:therapeutic use; D012702:Serotonin Antagonists / Q000009:adverse effects* / Q000627:therapeutic use
D010091:Oximes; D012702:Serotonin Antagonists; D005473:Fluoxetine; D016666:Fluvoxamine